The underlying mechanisms include reducing Apolipoprotein E (ApoE) expression and promoting autophagic flux following rTMS treatment, which is in line with a previous finding that rTMS promotes the BBB-mediated drainage efficiency of the brain clearance pathways in an AD animal model [171, 174]. The gene discussed is APOE; the disease is Alzheimer disease.